• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脚本化斑点去除在 PBS 质子治疗计划中。

Scripted spot removal in PBS proton therapy planning.

机构信息

Provision CARES Proton Therapy Center, Knoxville, Tennessee, USA.

出版信息

J Appl Clin Med Phys. 2022 Feb;23(2):e13491. doi: 10.1002/acm2.13491. Epub 2021 Dec 10.

DOI:10.1002/acm2.13491
PMID:34890101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8833280/
Abstract

BACKGROUND

It is well known in proton therapy that the relative biological effectiveness (RBE) is not constant across the entire Bragg peak, with higher RBE at the distal end of the Bragg peak due to higher linear energy transfer (LET). Treatment planning systems are moving toward LET optimization to mitigate this potentially higher biological impact at a track end. However, using a simple script, proton users can begin to simulate this process by deleting spots from critical structures during optimization. In most cases, nominal target coverage and plan robustness remain satisfactory.

METHODS

In our clinic, we developed a script that allows the user to delete spots in all organs at risk (OARs) of interest for one or more treatment beams. The purpose of this script is to potentially reduce side effects by eliminating Bragg peaks within OARs. The script was first used for prostate patients where spots in the rectum and sigmoid, outside of the overlap with the target, were deleted. We then began to use the script for head and neck (H&N) and breast/chestwall patients to reduce acute side effects of the skin by removing spots in a 0.5-cm skin rind.

CONCLUSIONS

By utilizing a simple script for deleting spots in critical structures, we have seen excellent clinical results thus far. We have noted reduced skin reactions for nearly all H&N and breast patients.

摘要

背景

在质子治疗中,众所周知相对生物效应(RBE)并非在整个布拉格峰中保持不变,由于较高的线性能量传递(LET),布拉格峰的远端 RBE 更高。治疗计划系统正在朝着 LET 优化的方向发展,以减轻在轨道末端可能更高的生物学影响。然而,质子使用者只需使用一个简单的脚本,就可以通过在优化过程中从关键结构中删除点来开始模拟这个过程。在大多数情况下,名义上的目标覆盖率和计划稳健性仍然令人满意。

方法

在我们的诊所,我们开发了一个脚本,允许用户为一个或多个治疗束删除所有感兴趣的危及器官(OAR)中的点。该脚本的目的是通过消除 OAR 内的布拉格峰来潜在地减少副作用。该脚本首先用于前列腺患者,在目标重叠之外的直肠和乙状结肠中删除点。然后,我们开始将脚本用于头颈部(H&N)和乳房/胸壁患者,通过去除 0.5 厘米的皮肤边缘中的点来减少皮肤的急性副作用。

结论

通过使用一个简单的脚本从关键结构中删除点,我们迄今为止已经看到了出色的临床结果。我们注意到几乎所有 H&N 和乳房患者的皮肤反应都有所减轻。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/434f/8833280/e99e44fecca2/ACM2-23-e13491-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/434f/8833280/5cd9d7143363/ACM2-23-e13491-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/434f/8833280/7a7a31e2eebc/ACM2-23-e13491-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/434f/8833280/eab09b571132/ACM2-23-e13491-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/434f/8833280/3d1947d482af/ACM2-23-e13491-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/434f/8833280/c8dc2fe26c28/ACM2-23-e13491-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/434f/8833280/e99e44fecca2/ACM2-23-e13491-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/434f/8833280/5cd9d7143363/ACM2-23-e13491-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/434f/8833280/7a7a31e2eebc/ACM2-23-e13491-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/434f/8833280/eab09b571132/ACM2-23-e13491-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/434f/8833280/3d1947d482af/ACM2-23-e13491-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/434f/8833280/c8dc2fe26c28/ACM2-23-e13491-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/434f/8833280/e99e44fecca2/ACM2-23-e13491-g005.jpg

相似文献

1
Scripted spot removal in PBS proton therapy planning.脚本化斑点去除在 PBS 质子治疗计划中。
J Appl Clin Med Phys. 2022 Feb;23(2):e13491. doi: 10.1002/acm2.13491. Epub 2021 Dec 10.
2
Robust intensity-modulated proton therapy to reduce high linear energy transfer in organs at risk.采用稳健的强度调制质子治疗以降低高线性能量转移的风险器官。
Med Phys. 2017 Dec;44(12):6138-6147. doi: 10.1002/mp.12610. Epub 2017 Oct 26.
3
Impact of Multiple Beams on Plan Quality, Linear Energy Transfer Distribution, and Plan Robustness of Intensity Modulated Proton Therapy for Lung Cancer.多束射束对肺癌调强质子治疗的计划质量、线性能量传递分布及计划稳健性的影响
ACS Sens. 2021 Feb 26;6(2):408-417. doi: 10.1021/acssensors.0c01879. Epub 2020 Oct 30.
4
Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.在调强质子治疗优化中引入质子射程末端目标以降低关键结构中的线性能量传递和相对生物效应。
Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):747-757. doi: 10.1016/j.ijrobp.2018.10.031. Epub 2018 Nov 2.
5
A biological effect-guided optimization approach using beam distal-edge avoidance for intensity-modulated proton therapy.一种使用射束远端边缘避让的生物效应引导优化方法用于调强质子治疗。
Med Phys. 2020 Sep;47(9):3816-3825. doi: 10.1002/mp.14335. Epub 2020 Jul 13.
6
Impact of range uncertainty on clinical distributions of linear energy transfer and biological effectiveness in proton therapy.射程不确定性对质子治疗中传能线密度和生物有效性临床分布的影响
Med Phys. 2020 Dec;47(12):6151-6162. doi: 10.1002/mp.14560. Epub 2020 Nov 14.
7
Considerations for shoot-through FLASH proton therapy.考虑到贯穿闪烁质子治疗。
Phys Med Biol. 2021 Mar 2;66(6):06NT01. doi: 10.1088/1361-6560/abe55a.
8
Linear energy transfer weighted beam orientation optimization for intensity-modulated proton therapy.线性能量转移加权质子调强治疗的射束方向优化。
Med Phys. 2021 Jan;48(1):57-70. doi: 10.1002/mp.14329. Epub 2020 Jul 13.
9
Biological dose and complication probabilities for the rectum and bladder based on linear energy transfer distributions in spot scanning proton therapy of prostate cancer.基于前列腺癌点扫描质子治疗中线性能量转移分布的直肠和膀胱的生物剂量及并发症概率
Acta Oncol. 2017 Nov;56(11):1413-1419. doi: 10.1080/0284186X.2017.1373198. Epub 2017 Oct 17.
10
Linear energy transfer-guided optimization in intensity modulated proton therapy: feasibility study and clinical potential.线性能量传递引导的调强质子治疗优化:可行性研究和临床潜力。
Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):216-22. doi: 10.1016/j.ijrobp.2013.05.013. Epub 2013 Jun 19.

引用本文的文献

1
Reducing Radiation Dermatitis for PBS Proton Therapy Breast Cancer Patients Using SpotDelete.使用SpotDelete减少PBS质子治疗乳腺癌患者的放射性皮炎
Int J Part Ther. 2024 Aug 28;13:100628. doi: 10.1016/j.ijpt.2024.100628. eCollection 2024 Sep.
2
Proton PBS Planning Techniques, Robustness Evaluation, and OAR Sparing for the Whole-Brain Part of Craniospinal Axis Irradiation.质子笔形束扫描计划技术、稳健性评估以及全脑脊髓轴照射中对危及器官的保护
Cancers (Basel). 2024 Feb 22;16(5):892. doi: 10.3390/cancers16050892.

本文引用的文献

1
Exponential Increase in Relative Biological Effectiveness Along Distal Edge of a Proton Bragg Peak as Measured by Deoxyribonucleic Acid Double-Strand Breaks.通过脱氧核糖核酸双链断裂测量质子布拉格峰远端边缘相对生物效应的指数增加。
Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):62-69. doi: 10.1016/j.ijrobp.2016.02.018. Epub 2016 Feb 13.
2
Direct evaluation of radiobiological parameters from clinical data in the case of ion beam therapy: an alternative approach to the relative biological effectiveness.离子束治疗中基于临床数据直接评估放射生物学参数:相对生物学效应的一种替代方法
Phys Med Biol. 2014 Dec 7;59(23):7393-417. doi: 10.1088/0031-9155/59/23/7393. Epub 2014 Nov 11.
3
Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer.
质子束治疗的相对生物效应(RBE)值。作为生物终点、剂量和线能量转移函数的变化。
Phys Med Biol. 2014 Nov 21;59(22):R419-72. doi: 10.1088/0031-9155/59/22/R419. Epub 2014 Oct 31.
4
Relative biological effectiveness variation along monoenergetic and modulated Bragg peaks of a 62-MeV therapeutic proton beam: a preclinical assessment.62兆电子伏特治疗质子束单能和调制布拉格峰的相对生物效应变化:一项临床前评估。
Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):27-35. doi: 10.1016/j.ijrobp.2014.05.010. Epub 2014 Jun 28.
5
Enhanced radiobiological effects at the distal end of a clinical proton beam: in vitro study.临床质子束远端增强的放射生物学效应:体外研究
J Radiat Res. 2014 Jul;55(4):816-22. doi: 10.1093/jrr/rrt230. Epub 2014 May 13.
6
Biological considerations when comparing proton therapy with photon therapy.比较质子治疗与光子治疗时的生物学考虑。
Semin Radiat Oncol. 2013 Apr;23(2):77-87. doi: 10.1016/j.semradonc.2012.11.002.
7
Variations in the RBE for cell killing along the depth-dose profile of a modulated proton therapy beam.调制质子治疗束深度剂量分布中细胞杀伤的 RBE 变化。
Radiat Res. 2013 Jan;179(1):21-8. doi: 10.1667/RR2737.1. Epub 2012 Nov 13.
8
A phenomenological model for the relative biological effectiveness in therapeutic proton beams.一种用于治疗质子束相对生物有效性的现象学模型。
Phys Med Biol. 2004 Jul 7;49(13):2811-25. doi: 10.1088/0031-9155/49/13/004.
9
Relative biological effectiveness of proton beams in clinical therapy.质子束在临床治疗中的相对生物效应
Radiother Oncol. 1999 Feb;50(2):135-42. doi: 10.1016/s0167-8140(98)00092-9.